High blood pressure treatment: ARBs vs. ACE inhibitors
Recent research from Geisinger Medical Center has brought new insights into treating high blood pressure, particularly for those starting treatment.
The study compares two popular...
Diastolic blood pressure: a key indicator of brain health risks
A recent study led by Michelle R. Caunca at the University of Miami has revealed a significant link between diastolic blood pressure and the...
Common blood pressure drugs linked to cognitive decline
A study from the University of California, San Diego, has uncovered a worrying link between widely used anticholinergic drugs and an increased risk of...
Vitamin B plays a big Role in managing drug-resistant high blood pressure
A collaborative study led by the University of Maine reveals that Vitamin B supplements could be a key strategy in controlling drug-resistant high blood...
This blood pressure number is very important for stroke prediction
A groundbreaking study by the University of Miami has unveiled a crucial connection between diastolic blood pressure and the health of the brain, particularly...
Exercise prescriptions for better high blood pressure and cholesterol control
In a significant move by the American Heart Association (AHA), doctors are being urged to prescribe exercise to adults with mildly high blood pressure...
Cut salt, cut blood pressure
Nearly everyone can lower their blood pressure, even people currently on blood pressure-reducing drugs, by lowering their sodium intake, reports a new study from...
Short sleep and shift work may increase high blood pressure risk
The Impact of Sleep on Blood Pressure
Researchers from the Baker Heart and Diabetes Institute have uncovered a critical link between sleep habits and the...
Common blood pressure drugs linked to eye disease glaucoma risk
A recent study has raised concerns about a certain type of blood pressure medication known as Calcium Channel Blockers (CCBs) and its potential association...
Promising new therapy strongly reduces big heart disease risk factor
Exciting findings from a Phase I trial conducted by a Cleveland Clinic physician reveal the effectiveness of an experimental therapy in dramatically reducing levels...